LAROCHE RICHARD F JR 4

What Happened

• Richard F. LaRoche Jr., a director of National Healthcare Corp (NHC), received a grant of 7,500 derivative securities reported as stock options on May 7, 2026. The Form 4 records the price as $0.00 (grant), so no cash purchase was made; this is an award of options rather than an open-market buy.

Key Details

• Transaction date: 2026-05-07
• Transaction type/code: Grant/Award (A) — derivative securities (stock options)
• Amount: 7,500 options; reported price on form: $0.00
• Shares owned after transaction: Not provided in the excerpt
• Footnote: Grant made under the 2020 Omnibus Equity Incentive Plan; exempt from Section 16(b) under Rule 16b-3(d) (per footnote F1)
• Filing timeliness: Reported and filed on 2026-05-07 (no late filing indicated)

Context

• These are option awards (a form of equity compensation) and do not represent an immediate market purchase or sale. Options typically vest over time and must be exercised before they convert to shares; they do not provide immediate cash unless exercised and sold. Director grants are common as compensation and should be viewed differently from open-market purchases when assessing insider sentiment.